SFT — Sopharma Trading AD Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual income statement for Sopharma Trading AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,165	1,344	1,487	1,681	1,947
Cost of Revenue
Gross Profit	99.9	133	159	175	223
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,148	1,330	1,469	1,636	1,885
Operating Profit	17.7	13.8	18.3	44.6	61.7
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13.9	9.44	12.4	34.2	46.9
Provision for Income Taxes
Net Income After Taxes	11.5	8.05	9.08	29.2	42.3
Net Income Before Extraordinary Items
Net Income	11.5	8.05	9.08	29.2	42.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	11.5	8.05	9.08	29.2	42.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.335	0.235	0.737	0.862	1.23
Dividends per Share